The AstraZeneca Covid vaccine, linked to a serious side-effect, has been discontinued for use in Australia.
QUICK FACTS:
- After being linked to a serious side-effect, the AstraZeneca COVID shot has been “quietly discontinued” from use in the country of Australia.
- The federal health department confirmed that beginning March 20, the vaccine, sold under the brand-name “Vaxzevria,” would no longer be available to Australians.
- Deakin University Chair in Epidemiology, Professor Catherine Bennett said the removal of the shot was expected after other vaccines emerged, but was kept by the country for people who wanted to “complete their course.”
- “It was really only left available for this long for people who had earlier doses of AstraZeneca and wanted to complete their course with it,” Bennett said.
- The AstraZeneca vaccine was approved for its first round in February 2021 and as a booster in February 2022 for individuals over the age of 18.
- In October 2021, the shot was made available by “request only” over concerns about a blood clotting disorder.
- The disorder, “thrombosis with thrombocytopenia,” involves low levels of blood platelets combined with blood clots and puts people under the age of 60 at greater risk.
- In June 2022, data from the Therapeutic Goods Administration reported eight deaths from TTS in Australia as a result of the AstraZeneca jab.
ASTRAZENECA ON “RARE” BLOOD CLOTTING DISORDERS ASSOCIATED WITH THEIR COVID VACCINE:
The pharmaceutical company said it is “actively working with the regulators and scientific community to understand these extremely rare blood-clotting events, including information to drive early diagnosis and intervention, and appropriate treatment.”
BACKGROUND:
- Last month, a group of families and patients in the UK reported to be suing AstraZeneca, claiming that their loved ones suffered severe reactions or died after taking the vaccine.
- Peter Todd, a consultant solicitor with Scott-Moncrieff & Associates, represented the group and initiated a claim against AstraZeneca under the Consumer Protection Act 1987.
- “I have started a claim against AstraZeneca seeking damages for injury (namely thrombosis with thrombocytopenia) and consequential loss caused by their COVID vaccine,” Todd said.
- “The claim is under the Consumer Protection Act 1987, which holds manufacturers liable for injury caused by a defective product,” he added.
- In April 2022, a recording obtained by Project Veritas revealed AstraZeneca CEO Pascal Soriot saying “millions of immunocompromised people can’t be vaccinated.”
- “Like if you have an immune disease, lupus, or some other immune condition, you cannot—or multiple sclerosis, you can’t be vaccinated,” Soriot said. “So, there are millions of people in the world that will need a protection that cannot be coming from a vaccine.”
- The video surfaced just one month after the World Health Organization (WHO) had claimed that the AstraZeneca vaccine was completely safe for those with compromised immune systems.
